PRPH-1: A Potential Drug Target and Biomarker (G5630)

Target Name: PRPH

NCBI ID: G5630

PRPH

PRPH-1: A Potential Drug Target and Biomarker

PRPH-1 (PeriProt/HSP70-1) is a protein that is expressed in various tissues and cells throughout the body. It is a member of the protamine HSP70 family, which is a subgroup of the protein superfamily known as the HSP70 family. PRPH -1 has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and stress response.

Recent studies have suggested that PRPH-1 may have potential as a drug target or biomarker. One of the main reasons for this is the fact that PRPH-1 is involved in multiple signaling pathways that are involved in various diseases, including cancer, neurodegenerative diseases , and autoimmune disorders.

One of the signaling pathways that is regulated by PRPH-1 is the PI3K/Akt signaling pathway. This pathway is involved in the regulation of cellular signaling, and has been implicated in the development and progression of many diseases, including cancer.

Studies have shown that PRPH-1 is a positive regulator of the PI3K/Akt pathway, and that it can increase the activity of the protein kinase Akt. This increase in activity can lead to the downstream regulation of many cellular processes, including cell growth, differentiation, and survival.

Another signaling pathway that is regulated by PRPH-1 is the p53 signaling pathway. This pathway is involved in the regulation of DNA replication and repair, and has been implicated in the development and progression of many diseases, including cancer.

Studies have shown that PRPH-1 is a negative regulator of the p53 pathway, and that it can inhibit the activity of the protein p53. This inhibition can lead to the downstream regulation of many cellular processes, including cell growth, apoptosis, and DNA replication.

In addition to its role in the PI3K/Akt and p53 signaling pathways, PRPH-1 has also been shown to be involved in the regulation of cellular stress responses. cellular stress responses are critical for the survival of cells in various environments, including the inside of the body.

Studies have shown that PRPH-1 is involved in the regulation of cellular stress responses, and that it can increase the activity of the protein heat shock protein (Hsp70). Hsp70 is a protein that is involved in the regulation of cellular stress responses, and has been shown to play a role in the development and progression of many diseases, including cancer.

Based on these findings, it is clear that PRPH-1 is a protein that is involved in the regulation of multiple cellular processes, and that it has the potential as a drug target or biomarker. Further studies are needed to fully understand the role of PRPH -1 in cellular signaling and the development and progression of diseases.

Protein Name: Peripherin

Functions: Class-III neuronal intermediate filament protein (By similarity). May form an independent structural network without the involvement of other neurofilaments or may cooperate with the neuronal intermediate filament proteins NEFL, NEFH, NEFM and INA to form a filamentous network (PubMed:15446584, PubMed:15322088). Assembly of the neuronal intermediate filaments may be regulated by RAB7A (By similarity). Plays a role in the development of unmyelinated sensory neurons (By similarity). May be involved in axon elongation and axon regeneration after injury (By similarity). Inhibits neurite extension in type II spiral ganglion neurons in the cochlea (By similarity)

The "PRPH Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRPH comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets